By using microarrays, Karlic et al. reported the ability of simvastatin to decrease the mRNA level of DNMT1 in MDA-MB-231 breast cancer cells, PC-3 prostate carcinoma cells, and U2 osteosarcoma cells, but not significantly [55]. This evidence concerns the gene DNMT1 and prostate carcinoma.